The Latest

Whether you're a patient, clinician, retailer or researcher, come with us as we work to bring quality, accessible cannabis care (and data) to all.

Featured

News

EO Care Appoints William Fleming and Kristi Savacool to Board of Directors

March 11, 2026

EO Team

EO Care has appointed healthcare leaders William Fleming (former Humana executive) and Kristi Savacool (former Aon Hewitt CEO) to its Board of Directors, strengthening governance as cannabinoid-based symptom management enters mainstream healthcare.

News

Cannabis Rescheduling: A Turning Point for Symptom Management in Healthcare

A major policy shift is reshaping how providers and payers approach symptom management. Here’s what cannabis rescheduling means for clinical care, reimbursement, and patient outcomes.

News

EO Data & Methodology: November 2025 Update

At EO, we systematically track how patients feel and function after starting guided cannabis care. The data below come from real people using cannabis to manage symptoms such as pain, sleep disturbance, anxiety, and nausea/vomiting, under the guidance of our clinical protocols.

News

Cannabis Rescheduling: A Turning Point for Symptom Management in Healthcare

A major policy shift is reshaping how providers and payers approach symptom management. Here’s what cannabis rescheduling means for clinical care, reimbursement, and patient outcomes.

News

EO Care Appoints William Fleming and Kristi Savacool to Board of Directors

Education

CBC vs CBD

Discover the differences between CBC vs CBD, how each works in the body, when they may be most useful, and whether combining them makes sense for your needs.

Education

THC For Neuropathy

Discover how THC may help manage neuropathy symptoms, what forms of THC are commonly used, and how to approach cannabis care safely.

Education

How to Use Cannabis Tinctures: A Beginner’s Guide

Learn what a cannabis tincture is, why people choose it, how to measure and take it correctly, and how to adjust your dosage safely over time.

News

EO Care, Inc. Statement on Cannabinoid Policy Announcements

The Administration’s decision to move to reclassify cannabis from Schedule I to Schedule III is a watershed moment for adult Americans who currently or might benefit from the responsible use of cannabinoids, especially oncology patients and older adults. It’s a long overdue step that will reduce stigma, open doors for essential research and product development, and increase access to care for patients.

News

EO Care, Inc. Statement on Proposed Federal Register Change

As the leader in cannabinoid based symptom management for older adults, we applaud the Centers for Medicare & Medicaid Services (CMS) proposal to expand coverage for federally legal, hemp-derived cannabinoid-based products. At EO, we are uniquely positioned to meet the need of this new, covered cannabinoid care market.

News

EO Data & Methodology: November 2025 Update

News

EO Care Releases Latest Cannabinoid-Based Symptom Management Efficacy Data

Meaningful improvements were reported by patients after one (1) week and sustained through four (4) weeks of guided cannabinoid care, particularly among people over 50 and cancer patients. Patients also reported low rates of use-limiting side effects with further reductions after receiving updated recommended product and/or dosing guidance via EO Care’s digital care platform.

News

EO Launches Its Next Generation Cannabinoid Care Platform

New scalable, digital health offering makes personalized, clinically responsible cannabinoid guidance accessible to all older adults, adults in cancer treatment and cancer survivors.‍The platform was designed and tested with patients and clinicians at leading hospitals and NCI-Designated Cancer Centers.

Education

Cannabis Tinctures vs. Edibles: Which Is Right for You?

Learn the differences between tinctures and edibles as well as how to choose the format that best matches your symptoms, schedule, and personal preferences.

Education

Cannabis vs. Tylenol: Can You Use Both?

Learn how acetaminophen and THC act in the body, what current research shows about using them together, and when cannabis may be the better option.

The Latest

Featured

EO Care Appoints William Fleming and Kristi Savacool to Board of Directors

Cannabis Rescheduling: A Turning Point for Symptom Management in Healthcare

EO Data & Methodology: November 2025 Update

Cannabis Rescheduling: A Turning Point for Symptom Management in Healthcare

EO Care Appoints William Fleming and Kristi Savacool to Board of Directors

CBC vs CBD

THC For Neuropathy

How to Use Cannabis Tinctures: A Beginner’s Guide

EO Care, Inc. Statement on Cannabinoid Policy Announcements

EO Care, Inc. Statement on Proposed Federal Register Change

EO Data & Methodology: November 2025 Update

EO Care Releases Latest Cannabinoid-Based Symptom Management Efficacy Data

EO Launches Its Next Generation Cannabinoid Care Platform

Cannabis Tinctures vs. Edibles: Which Is Right for You?

Cannabis vs. Tylenol: Can You Use Both?

EO in Your Inbox